J&J Medical Connect
TREMFYA®

(guselkumab)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TREMFYA® (guselkumab)

Medical Information

TREMFYA – Use in Combination with TNF Inhibitors for the Treatment of Psoriatic Arthritis in Adult Patients – Real-World Evidence

Last Updated: 03/24/2026

SUMMARY  

  • The company cannot recommend any practices, procedures or usage that deviate from the approved labeling.
  • There are no relevant data available from real-world evidence regarding the use of TREMFYA in combination with tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis in adult patients.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 04 February 2026 did not identify any relevant citations pertaining to this topic.